GRM5 and Alzheimer disease: The non-displaceable binding potential (BPND) of [18F]FPEB, a mGluR5-specific radiotracer, revealed significant reductions in the hippocampus mGluR5 availability in sixteen individuals diagnosed with mild cognitive impairment (MCI) due to AD or mild AD dementia [14].